CJC-1295 (without DAC)
A short-acting copy of the brain signal that tells the pituitary gland to release growth hormone in short bursts.
Learn about CJC-1295 (without DAC)A named pairing of two growth hormone peptides that reach the pituitary gland through two different doors.
CJC-1295 / Ipamorelin is a clinic name for using two peptides together. CJC-1295 copies the brain's growth hormone signal; ipamorelin works through a separate receptor in the pituitary gland.
Using two compounds together deserves extra care. We describe each one on its own page and do not suggest any specific pairing, ratio, or schedule.
This is a clinic naming convention rather than a manufactured product. It refers to using two growth hormone peptides together.
The reasoning is that they reach the pituitary gland through different receptors, so the thinking goes that the two signals add up.
That reasoning is plausible, but the pairing has not been studied as a product, and neither peptide is approved on its own.
The pituitary gland releases growth hormone in bursts, and two separate signals influence when those bursts happen.
CJC-1295 copies the brain's releasing hormone, which is one signal. Ipamorelin works on the ghrelin receptor, which is the other.
Using both is meant to press two levers at once rather than one. Growth hormone then raises IGF-1, which does most of the downstream work.
Which CJC-1295 form is meant matters a great deal, since one lasts hours and the other lasts days. We describe each on its own page and do not suggest any specific pairing, ratio, or schedule.
Adults looking at lean muscle, body composition, and recovery through the growth hormone system
People researching CJC-1295 or ipamorelin individually who keep running into the paired name
Adults interested in sleep quality and overnight recovery
People weighing a single compound against using two together
How this compound compares to related options in the wellness landscape.
One half of the pairing, and it can be used on its own.
The other half, in its short-acting form. A long-acting version also exists.
An FDA-approved releaser for one specific condition. Approval is the clearest difference.
Other compounds that support overlapping wellness goals.
A short-acting copy of the brain signal that tells the pituitary gland to release growth hormone in short bursts.
Learn about CJC-1295 (without DAC)A longer-acting copy of the brain signal for growth hormone, changed so it sticks to a blood protein and stays active for days.
Learn about CJC-1295 (with DAC)A lab-made peptide that nudges the pituitary gland to release growth hormone in its normal on-and-off pattern.
Learn about IpamorelinA prescription copy of the brain signal for growth hormone, approved to reduce excess belly fat in adults living with HIV.
Learn about TesamorelinThis pairing is not FDA-approved. That means the FDA has not reviewed it for safety or effectiveness for the uses described here. Neither peptide is approved on its own, and the combination has not been studied as a product.
Peptides in our shop are sourced from US-licensed manufacturers.
This is a clinic pairing name, not an FDA-approved product, and neither peptide is approved on its own.
Using two compounds together makes it harder to tell what helped and what caused a side effect.
Raising growth hormone can affect blood sugar and can cause fluid retention or joint aches.
We describe each peptide on its own page and do not suggest any specific pairing, ratio, or schedule.
See current pricing and availability for CJC-1295 / Ipamorelin in our shop. If a medical evaluation is needed, a licensed provider guides you through it.
Individual results vary. General information on this site is not a substitute for professional medical advice.